United States v. Hammonds

370 F.3d 1032, 2004 U.S. App. LEXIS 11020, 2004 WL 1234149
CourtCourt of Appeals for the Tenth Circuit
DecidedJune 4, 2004
Docket03-7081
StatusPublished
Cited by25 cases

This text of 370 F.3d 1032 (United States v. Hammonds) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Hammonds, 370 F.3d 1032, 2004 U.S. App. LEXIS 11020, 2004 WL 1234149 (10th Cir. 2004).

Opinion

STEPHEN H. ANDERSON, Circuit Judge.

The issue before us in this case is whether the district court erred in revoking the defendant-appellant’s term of supervised release under 18 U.S.C. § 3583(g)(1), which mandates revocation for “possession” of a controlled substance, based on a single positive urinalysis result. For the reasons set forth below, we affirm the district court’s revocation order.

BACKGROUND

On March 23, 1999, Tilman Eugene Hammonds pled guilty to a charge of being a felon in possession of a firearm, in violation of 18 U.S.C. § 922(g), and was sentenced, on July 13, 1999, to seventy months’ imprisonment, followed by three years of supervised release. The sentencing court recommended “[t]hat defendant be given the opportunity to participate in an intensive substance abuse treatment program [in prison].” R. Vol. I, tab 11 at 2. The court also imposed the following conditions on Hammonds’ supervised release, as required under 18 U.S.C. § 3583(d):

The defendant shall not illegally possess a controlled substance.
The defendant shall refrain from any unlawful use of a controlled substance. The defendant shall submit to one drug test within 15 days of release from im *1034 prisonment and at least two periodic drug tests thereafter, as directed by the probation officer.

Id. at 3. Due to his cooperation in another case, Hammonds’ term of imprisonment was subsequently reduced to forty-six months. His term of supervised release began on May 1, 2002.

On May 28, 2003, Hammonds submitted a urine sample that tested positive for amphetamine, methamphetamine, and d-methamphetamine. The test results were reported on June 9, 2003. On June 17, 2003, Hammonds’ probation officer submitted a petition to the district court recommending revocation of Hammonds’ term of supervised release based on this positive urinalysis result.

The court held a final revocation hearing on July 15, 2003. At the hearing, both parties stipulated to the May 28 positive urinalysis result and the fact that this was the only positive result during Hammonds’ supervised release to date. Hammonds presented his probation officer as a witness. The probation officer testified that, due to Hammonds’ participation as a witness in state prosecutions, Hammonds had changed prisons several times and had at one point been put in protective segregation. The officer further testified that Hammonds had not participated in a drug treatment program until the final six months of his incarceration, after he moved into a halfway house.

On the basis of this testimony, Ham-monds urged the court not to revoke his term of supervised release but instead to order him to enroll in a drug treatment program. However, the government argued for revocation, stating that “as to this defendant, he has had some drug treatment already and has failed, even following that treatment, to comply with the rules and conditions of probation regarding illegal drug use.” Hr’g Tr. at 10, R. Vol. II.

The district court made a finding, by a preponderance of the evidence, that, based on Hammonds’ May 28 positive urinalysis, Hammonds violated the mandatory condition of his supervised release prohibiting him from illegally possessing a controlled substance. The court thereupon revoked Hammonds’ term of supervised release and sentenced Hammonds to twenty-four months’ imprisonment. The court also recommended “[t]hat the defendant be given the opportunity to participate in an intensive substance abuse treatment program.” R. Vol. I, tab 23 at 2.

Hammonds brought this appeal, arguing that the district court misapplied the mandatory revocation requirements of 18 U.S.C. § 3583(g) in light of Congress’s 2002 amendments to the statute. We review orders revoking supervised release for an abuse of discretion. United States v. McAfee, 998 F.2d 835, 837 (10th Cir.1993). “[H]owever, we review de novo legal questions relating to the applicability of 18 U.S.C. § 3583(g).” Id.

DISCUSSION

We understand Hammonds’ arguments on appeal to be, in essence, twofold. First, Hammonds argues Congress’s 2002 addition of subsection (g)(4) to 18 U.S.C. § 3583 requires us to reconsider our prior holding in United States v. Rockwell, 984 F.2d 1112 (10th Cir.1993), overruled on other grounds by Johnson v. United States, 529 U.S. 694, 120 S.Ct. 1795, 146 L.Ed.2d 727 (2000), concerning the relationship between drug use and drug possession in the revocation context. Second, Hammonds argues the district court erred by not granting him, pursuant to 18 U.S.C. § 3583(d), an exception to subsection (g)’s mandatory revocation requirement. We address each of these arguments in turn.

*1035 A.

Hammonds’ first argument focuses on 18 U.S.C. § 3583(g), which currently states, in relevant part:

(g) Mandatory revocation for possession of controlled substance ... or for refusal to comply with drug testing.— If the defendant—
(1) possesses a controlled substance in violation of the condition set forth in subsection (d); 1
(3) refuses to comply with drug testing imposed as a condition of supervised release; or
(4) as a part of drug testing, tests positive for illegal controlled substances more than 3 times over the course of 1 year;
the court shall revoke the term of supervised release and require the defendant to serve a term of imprisonment not to exceed the maximum term of imprisonment authorized under subsection (e)(3).

18 U.S.C. § 3583(g). Hammonds’ term of supervised release was revoked under subsection (g)(1), after the district court found, based on a positive urinalysis result, that Hammonds possessed a controlled substance.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Davey
Tenth Circuit, 2025
SPIVEY v. POLK
N.D. Florida, 2024
United States v. Anthony Smith
Eighth Circuit, 2024
United States v. Richardson
Tenth Circuit, 2023
United States v. Rhodes
Tenth Circuit, 2021
United States v. Rodriguez
945 F.3d 1245 (Tenth Circuit, 2019)
United States v. Jack Garner
Sixth Circuit, 2019
United States v. John Brooker
858 F.3d 983 (Fifth Circuit, 2017)
United States v. James
603 F. App'x 717 (Tenth Circuit, 2015)
United States v. Murphy
560 F. App'x 776 (Tenth Circuit, 2014)
United States v. Dominique Weldon
538 F. App'x 301 (Fourth Circuit, 2013)
United States v. Steven Bell
535 F. App'x 256 (Fourth Circuit, 2013)
United States v. Keith Bell
483 F. App'x 804 (Fourth Circuit, 2012)
United States v. Acosta
480 F. App'x 923 (Tenth Circuit, 2012)
United States v. Hunt
673 F.3d 1289 (Tenth Circuit, 2012)
United States v. Lonjose
663 F.3d 1292 (Tenth Circuit, 2011)
United States v. Dodds
385 F. App'x 829 (Tenth Circuit, 2010)
United States v. Metzener
584 F.3d 928 (Tenth Circuit, 2009)
United States v. Riggans
346 F. App'x 309 (Tenth Circuit, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
370 F.3d 1032, 2004 U.S. App. LEXIS 11020, 2004 WL 1234149, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-hammonds-ca10-2004.